Expand Content

Journal Publications

Heart and Vascular Institute Publications 2010 - Present

We have included a selection of our staff physician journal publications from 2010 through December 2014. This is not a complete list. We have chosen journal articles based on the impact this journal has on the medical field as well as noted by our staff to be most utilized by their specialty.

American Heart Journal

2014

Bagai A, Schulte PJ, Granger CB, Mahaffey KW, Christenson RH, Bell G, Lopes RD, Green CL, Lincoff AM, Armstrong PW, Roe MT. Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. Am Heart J. 2014 Oct;168(4):503-511. [PM:25262260]

Cavalcante JL, Marwick TH, Hachamovitch R, Popovic ZB, Aldweib N, Starling RC, Desai MY, Flamm SD, Kwon DH. Is there a role for diastolic function assessment in era of delayed enhancement cardiac magnetic resonance imaging?: A multimodality imaging study in patients with advanced ischemic cardiomyopathy. Am Heart J. 2014 Aug;168(2):220-228. [PM:25066562]

Vora AN, Chenier M, Schulte PJ, Goodman S, Peterson ED, Pieper K, Jolicoeur ME, Mahaffey KW, White H, Wang TY. Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndrome. Am Heart J. 2014 Aug;168(2):189-196. [PM:25066558]

Ezekowitz MD, Cappato R, Klein AL, Camm AJ, Ma CS, Le Heuzey JY, Talajic M, Scanavacca MI, Vardas PE, Kirchhof P, Hohnloser SH, Hemmrich M, Lanius V, Meng IL, Wildgoose P, van Eickels M. Rationale and design of the eXplore the efficacy and safety of once-daily oral riVaroxaban for the prEvention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion trial: A comparison of oral rivaroxaban once daily with dose-adjusted vitamin K antagonists in patients with nonvalvular atrial fibrillation undergoing elective cardioversion. Am Heart J. 2014 May;167(5):646-652. [PM:24766973]

Whitlock R, Teoh K, Vincent J, Devereaux PJ, Lamy A, Paparella D, Zuo Y, Sessler DI, Shah P, Villar JC, Karthikeyan G, Urrutia G, Alvezum A, Zhang X, Abbasi SH, Zheng H, Quantz M, Yared JP, Yu H, Noiseux N, Yusuf S. Rationale and design of the Steroids in Cardiac Surgery trial. Am Heart J. 2014 May;167(5):660-665. [PM:24766975]


2013

Aldweib N, Negishi K, Seicean S, Jaber WA, Hachamovitch R, Cerqueira M, Marwick TH. Appropriate test selection for single-photon emission computed tomography imaging: Association with clinical risk, posttest management, and outcomes. Am Heart J. 2013 Sep;166(3):581-588. [PM:24016510]

Hsich EM, Grau-Sepulveda MV, Hernandez AF, Eapen ZJ, Xian Y, Schwamm LH, Bhatt DL, Fonarow GC. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: Findings from the Get With The Guideline-Heart Failure Registry. Am Heart J. 2013 Dec;166(6):1063-1071. [PM:24268222]

Kobayashi T, Popovic Z, Bhonsale A, Smedira NG, Tan C, Rodriguez ER, Thamilarasan M, Lytle BW, Lever HM, Desai MY. Association between septal strain rate and histopathology in symptomatic hypertrophic cardiomyopathy patients undergoing septal myectomy. Am Heart J. 2013 Sep;166(3):503-511. [PM:24016500]

Lincoff AM, Tardif JC, Neal B, Nicholls SJ, Ryden L, Schwartz GG, Malmberg K, Buse JB, Henry RR, Wedel H, Weichert A, Cannata R, Grobbee DE. Evaluation of the dual peroxisome proliferator-activated receptor alpha/gamma agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: Rationale and design of the AleCardio trial. Am Heart J. 2013 Sep;166(3):429-434. [PM:24016490]

Mampuya WM, Frid D, Rocco M, Huang J, Brennan DM, Hazen SL, Cho L. Treatment strategies in patients with statin intolerance: The Cleveland Clinic experience. Am Heart J. 2013 Sep;166(3):597-603. [PM:24016512]

Marso SP, Poulter NR, Nissen SE, Nauck MA, Zinman B, Daniels GH, Pocock S, Steinberg WM, Bergenstal RM, Mann JFE, Ravn LS, Frandsen KB, Moses AC, Buse JB. Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial. Am Heart J. 2013 Nov;166(5):823-830. [PM:24176437]


2011

De S, Borowski AG, Wang H, Nye L, Xin B, Thomas JD, Tang WHW. Subclinical echocardiographic abnormalities in phenotype-negative carriers of myosin-binding protein C3 gene mutation for hypertrophic cardiomyopathy. Am Heart J. 2011 Aug;162(2):262-267. [PM:21835286]


2010

Rader F, Van Wagoner DR, Gillinov AM, Blackstone EH. Preoperative angiotensin-blocking drug therapy is not associated with atrial fibrillation after cardiac surgery. Am Heart J. 2010 Aug;160(2):329-336.e1.

American Journal of Cardiology

2014

Alraies MC, Al Jaroudi W, Shabrang C, Yarmohammadi H, Klein AL, Tamarappoo BK. Clinical features associated with adverse events in patients with post-pericardiotomy syndrome following cardiac surgery. Am J Cardiol. 2014 Nov 1;114(9):1426-1430. [PM:25306427]

Beohar N, Zajarias A, Thourani VH, Herrmann HC, Mack M, Kapadia S, Green P, Arnold SV, Cohen DJ, Genereux P, Xu K, Leon MB, Kirtane AJ. Analysis of early out-of hospital mortality after transcatheter aortic valve implantation among patients with aortic stenosis successfully discharged from the hospital and alive at 30 days (from the Placement of Aortic Transcatheter Valves Trial). Am J Cardiol. 2014 Nov 15;114(10):1550-1555. [PM:25277334]

Kunadian V, Mehran R, Lincoff AM, Feit F, Manoukian SV, Hamon M, Cox DA, Dangas GD, Stone GW. Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). Am J Cardiol. 2014 Dec 15;114(12):1823-1829. [PM:25438908]

Mani P, Uno K, St John J, Tuzcu EM, Nissen SE, Nicholls SJ. Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients. Am J Cardiol. 2014 Sep 1;114(5):681-685. [PM:25030535]

Puri R, Nissen SE, Shao M, Uno K, Kataoka Y, Kapadia SR, Tuzcu EM, Nicholls SJ. Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy. Am J Cardiol. 2014 Nov 15;114(10):1465-1472. [PM:25282317]

Yousefzai R, Bajaj N, Krishnaswamy A, Goel SS, Agarwal S, Aksoy O, Aggarwal B, Duarte VE, Anabtawi A, Parashar A, Sodhi N, Thomas J, Griffin BP, Tuzcu EM, Kapadia SR. Outcomes of patients with ischemic mitral regurgitation undergoing percutaneous coronary intervention. Am J Cardiol. 2014 Oct 1;114(7):1011-1017. [PM:25118123]

Kataoka Y, Puri R, Hammadah M, Duggal B, Uno K, Kapadia SR, Tuzcu EM, Nissen SE, Nicholls SJ. Frequency-domain optical coherence tomographic analysis of plaque microstructures at nonculprit narrowings in patients receiving potent statin therapy. Am J Cardiol. 2014 Aug 15;114(4):549-554. [PM:24996554]

Reynard AK, Butler RS, McKee MG, Starling RC, Gorodeski EZ. Frequency of depression and anxiety before and after insertion of a continuous flow left ventricular assist device. Am J Cardiol. 2014 Aug 1;114(3):433-440. [PM:24931289]

Zdradzinski MJ, Qureshi AM, Stewart R, Pettersson G, Krasuski RA. Comparison of long-term postoperative sequelae in patients with tetralogy of fallot versus isolated pulmonic stenosis. Am J Cardiol. 2014 Jul 15;114(2):300-304. [PM:24878128]

Alraies MC, Kusunose K, Negishi K, Yarmohammadi H, Motoki H, AlJaroudi W, Popovic ZB, Klein AL. Relation between echocardiographically estimated and invasively measured filling pressures in constrictive pericarditis. Am J Cardiol. 2014 Jun 1;113(11):1911-1916. [PM:24837273]

Kobayashi T, Dhillon A, Popovic Z, Bhonsale A, Smedira NG, Thamilarasan M, Lytle BW, Lever HM, Desai MY. Differences in global and regional left ventricular myocardial mechanics in various morphologic subtypes of patients with obstructive hypertrophic cardiomyopathy referred for ventricular septal myotomy/myectomy. Am J Cardiol. 2014 Jun 1;113(11):1879-1885. [PM:24837268]

Oliveira GH, Mukerji S, Hernandez AV, Qattan MY, Banchs J, Durand JB, Iliescu C, Plana JC, Tang WHW. Incidence, predictors, and impact on survival of left ventricular systolic dysfunction and recovery in advanced cancer patients. Am J Cardiol. 2014 Jun 1;113(11):1893-1898. [PM:24837270]

Shao Z, Zhang R, Shrestha K, Borowski AG, Schuster A, Thakur A, Hazen SL, Tang WHW. Usefulness of elevated urine neopterin levels in assessing cardiac dysfunction and exercise ventilation inefficiency in patients with chronic systolic heart failure. Am J Cardiol. 2014 Jun 1;113(11):1839-1843. [PM:24837262]

Testani JM, Brisco MA, Han G, Laur O, Kula AJ, Cheng SJ, Tang WHW, Parikh CR. Influence of age-related versus non-age-related renal dysfunction on survival in patients with left ventricular dysfunction. Am J Cardiol. 2014 Jan 1;113(1):127-131. [PM:24216124]

Thavendiranathan P, Yingchoncharoen T, Grant A, Seicean S, Landers SH, Gorodeski EZ, Marwick TH. Prediction of 30-day heart failure-specific readmission risk by echocardiographic parameters. Am J Cardiol. 2014 Jan 15;113(2):335-341. [PM:24268036]


2013

Aggarwal B, Raymond C, Jacob J, Kralovic D, Kormos K, Holloway D, Menon V. Transfer of patients with suspected acute aortic syndrome. Am J Cardiol. 2013 Aug 1;112(3):430-435. [PM:23668639]

Green P, Cohen DJ, Genereux P, McAndrew T, Arnold SV, Alu M, Beohar N, Rihal CS, Mack MJ, Kapadia S, Dvir D, Maurer MS, Williams MR, Kodali S, Leon MB, Kirtane AJ. Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER Trial). Am J Cardiol. 2013 Sep 1;112(5):700-706. [PM:23725996]

Kusunose K, Kwon DH, Motoki H, Flamm SD, Marwick TH. Comparison of three-dimensional echocardiographic findings to those of magnetic resonance imaging for determination of left ventricular mass in patients with ischemic and non-ischemic cardiomyopathy. Am J Cardiol. 2013 Aug 15;112(4):604-611. [PM:23768466]

Motoki H, Borowski AG, Shrestha K, Troughton RW, Martin MG, Tang WHW, Klein AL. Impact of left ventricular diastolic function on left atrial mechanics in systolic heart failure. Am J Cardiol. 2013 Sep 15;112(6):821-826. [PM:23764244]

Novaro GM, Houghtaling PL, Gillinov AM, Blackstone EH, Asher CR. Prevalence of mitral valve prolapse and congenital bicuspid aortic valves in black and white patients undergoing cardiac valve operations. Am J Cardiol. 2013 Mar 15;111(6):898-901.

Verbrugge FH, Duchenne J, Bertrand PB, Dupont M, Tang WHW, Mullens W. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions. Am J Cardiol. 2013 Dec 15;112(12):1913-1920. [PM:24286620]

Yarmohammadi H, Klosterman T, Grewal G, Alraies MC, Varr BC, Lindsay B, Zurick AO, III, Shrestha K, Tang WHW, Bhargava M, Klein AL. Efficacy of the CHADS2 scoring system to assess left atrial thrombogenic milieu risk before cardioversion of non-valvular atrial fibrillation. Am J Cardiol. 2013 Sep 1;112(5):678-683. [PM:23726178]


2012

Gada H, Kapadia SR, Tuzcu EM, Svensson LG, Marwick TH. Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Cardiol. 2012 May 1;109(9):1326-1333.

Goel SS, Tuzcu EM, Agarwal S, Aksoy O, Krishnaswamy A, Griffin BP, Svensson LG, Kapadia SR. Comparison of ascending aortic size in patients with severe bicuspid aortic valve stenosis treated with versus without a statin drug. Am J Cardiol. 2011 Nov 15;108(10):1458-1462.

Jacob M, Smedira N, Blackstone E, Williams S, Cho L. Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in patients having combined coronary artery bypass grafting and valve surgery. Am J Cardiol. 2012 Mar 15;109(6):824-830.

Rassi AN, Blackstone E, Militello MA, Theodos G, Cavender MA, Sun Z, Ellis SG, Cho L. Safety of "bridging" with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgery. Am J Cardiol. 2012 Aug 15;110(4):485-490.

Shafii AE, Gillinov AM, Mihaljevic T, Stewart W, Batizy LH, Blackstone EH. Changes in left ventricular morphology and function after mitral valve surgery. Am J Cardiol. 2012 Aug 1;110(3):403-408.


2011

Kodali SK, O'Neill WW, Moses JW, Williams M, Smith CR, Tuzcu M, Svensson LG, Kapadia S, Hanzel G, Kirtane AJ, Leon MB. Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL Trial). Am J Cardiol. 2011 Apr 1;107(7):1058-1064.


2010

Matsumura Y, Gillinov AM, Toyono M, Oe H, Yamano T, Takasaki K, Saraiva RM, Shiota T. Echocardiographic predictors for persistent functional mitral regurgitation after aortic valve replacement in patients with aortic valve stenosis. Am J Cardiol. 2010 Sep 1;106(5):701-706.

Annals of Cardiothoracic Surgery

2014

Roselli EE. Optimization of distal landing zone for TEVAR in chronic dissection. Ann Cardiothorac Surg. 2014 May;3(3):329-332. [PM:24967175]

2013

Lytle BW. Bilateral internal thoracic artery grafting. Ann Cardiothorac Surg. 2013 Jul;2(4):485-492. [PM:23977627]

Navia JL, Olivares G, Ehasz P, Gillinov AM, Svensson LG, Brozzi N, Lytle B. Endoscopic radial artery harvesting procedure for coronary artery bypass grafting. Ann Cardiothorac Surg. 2013 Jul;2(4):557-564. [PM:23977636]

Roselli EE. We should replace the aortic arch and more in DeBakey type I dissection - A perspective from the Cleveland Clinic. Ann Cardiothorac Surg. 2013 Mar;2(2):216-221. [PM:23977586]

Roselli EE. Trade in the hammer for a power driver-perspectives on the frozen elephant trunk repair for aortic arch disease. Ann Cardiothorac Surg. 2013 Sep;2(5):633-639. [PM:24109573]

Annals of Internal Medicine

2014

Goel SS, Aksoy O, Gupta S, Houghtaling PL, Tuzcu EM, Marwick T, Mihaljevic T, Svensson L, Blackstone EH, Griffin BP, Stewart WJ, Barzilai B, Menon V, Kapadia SR. Renin-angiotensin system blockade therapy after surgical aortic valve replacement for severe aortic stenosis: a cohort study. Ann Intern Med. 2014 Nov 18;161(10):699-710. [PM:25402513]


2012

Nissen SE. Cardiovascular effects of diabetes drugs: emerging from the dark ages. Ann Intern Med. 2012 Nov 6;157(9):671-672. [PM:23128866]


2010

Rosenberg S, Elashoff MR, Beineke P, Daniels SE, Wingrove JA, Tingley WG, Sager PT, Sehnert AJ, Yau M, Kraus WE, Newby LK, Schwartz RS, Voros S, Ellis